Billionaire entrepreneur Mark Cuban has endorsed a healthcare plan proposed by Texas Senate candidate James Talarico that aims to lower prescription-drug costs and break up what they call Big Medicine monopolies, a move that could challenge CVS Health and other vertically integrated healthcare giants. The proposal, which is not yet law, targets the combination of insurers, pharmacy benefit managers, and healthcare providers that underpins CVS's strategy. CVS's integrated model includes Aetna insurance, CVS Caremark pharmacy-benefit management, retail pharmacies, and healthcare services, with Caremark managing benefits for roughly 87 million plan members and CVS serving over 37 million through insurance products. Talarico told CNBC his plan would pursue antitrust legislation against vertically integrated healthcare conglomerates, including PBMs, insurers, and hospital networks. Cuban, who co-founded the Mark Cuban Cost Plus Drug Company, said the plan aims for more affordable, better quality healthcare for all. The two are expected to promote the plan at an August 29 event in Fort Worth. UnitedHealth, Cigna, Elevance Health, and large hospital operators could also face scrutiny if lawmakers move to separate healthcare businesses or restrict vertical integration. For investors, the key point is that this is currently a political proposal, not an enacted regulatory change, but they should watch whether it gains broader congressional support and whether federal antitrust scrutiny intensifies.
CVS Health CorpProposed antitrust plan backed by Mark Cuban targets breaking up vertically integrated healthcare giants like CVS, directly challenging its insurer-PBM-provider model.
Cigna Corp
Elevance Health Inc
British American Tobacco PLC
UnitedHealth Group Incorporated